Home Financial News LLY Earnings: Eli Lilly Reports Impressive Q2 Results; Huge Revenue Increase –...
- LLY Earnings: Eli Lilly Reports Impressive Q2 Results; Huge Revenue Increase TipRanks
- Eli Lilly Stock Surges as Mounjaro and Zepbound Drugs Fuel Sales The Wall Street Journal
- Eli Lilly’s second quarter eases Zepound pricing fears and suggests it’s gaining ground in weight loss race CNBC
- Eli Lilly’s stock leaps after big earnings beat, boosted by strength in Mounjaro and Zepbound sales MarketWatch
- Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion Investors | Eli Lilly and Company